Michael Frumovitz, M.D., Endowment for Gynecologic Rare Tumors
Supporting the creation of an endowment to honor distinguished MD Anderson gynecologic oncologist, Dr. Michael Frumovitz, recognizes medical excellence in difficult-to-treat cancers — and the importance of the physician-investigators who bring hope, health and cures to the many who carry the burden of a cancer diagnosis.
The University of Texas MD Anderson Cancer Center has long been defined by its world-class, evidence-based patient care. MD Anderson experts discover, transform, impact and endure over the long term. As a testament to the best and brightest in medicine, the institution will establish an endowment to honor an outstanding physician deeply dedicated to the many vulnerable patients he has served. A gift to the Michael Frumovitz, M.D., Endowment for Gynecologic Rare Tumors will allow MD Anderson to continue making meaningful advances in this area of research.
Dr. Frumovitz is an internationally renowned expert who founded MD Anderson’s Rare Tumor Program. His work is pivotal to the medical advances we have made in a spectrum of rare gynecologic cancers. To build on this body of knowledge and a legacy of learning, this endowment will support clinical research and translational studies, medical education and lectures, training the next generation of leaders, and promoting a strong and accessible rare tumor research- based registry. By enriching the research and educational experiences found at the Department of Gynecologic Oncology and Reproductive Medicine, this endowed fund can elevate our global standing in the study of rare gynecologic cancers.
Exemplary commitment to knowledge and growth
As an outstanding clinician, gifted educator and innovative researcher, Dr. Frumovitz has made a lasting impact on gynecologic oncology at MD Anderson and within the medical community at large. He is considered a leading authority in rare tumors and especially small cell cancer of the cervix. He currently holds the titles of professor of Gynecologic Oncology and Chief Patient Experience Officer.
Likewise, Dr. Frumovitz is widely recognized for his years of service as director of the MD Anderson Gynecologic Oncology Fellowship, which is considered one of the top fellowships of its kind in the world. During his tenure, he led programmatic change and development of curriculum. In addition to leading MD Anderson’s National Institutes of Health T32 Training Grant, Dr. Frumovitz was a driving force for the program’s recognition by the Accreditation Council on Graduate Medical Education. As a strong and steadfast advocate for medical trainees, he focused on an individual’s professional development and how that can best align to the needs of patients and families we serve.
Dr. Frumovitz has championed the investigation of small cell neuroendocrine cancer of the cervix, a rare and devastating disease that affects young women. And MD Anderson’s Rare Tumors Program has grown exponentially from his prolific published works. Dr. Frumovitz has nearly 190 peer-reviewed articles, numerous editorials and invited articles, and 18 book chapters. He is also editor of two textbooks, one specifically on rare gynecologic tumors.
Compassionate, comprehensive patient care
During Dr. Frumovitz’s distinguished career, he has assembled an impressive patient registry that comprises women who travel nationally and internationally to seek MD Anderson’s guidance and care. For example, the Neuroendocrine Cervical Tumor Registry has recorded more than 500 patients with neuroendocrine carcinoma of the cervix. This demonstrates MD Anderson’s dedication and expertise with exceptionally rare cancers.
The educational website (www.necervix.com) and cancer registry highlight the most effective treatments of the day, as well as being a portal-of-support that connects patients. This registry has allowed Dr. Frumovitz to conduct meaningful research to better understand the underpinnings of this cancer and it has sparked clinical trial activities to innovate and improve patient outcomes. Moreover, Dr. Frumovitz meets with a vibrant group of survivors for an annual gathering — he is truly a beacon of hope and healing.
Your philanthropic impact
Philanthropic support enables and empowers us to build on the legacy of extraordinarily gifted physicians and investigators such as Dr. Frumovitz. Your generous gift will honor him by allowing us to advance the work he has begun — to stop the devastating impacts of rare gynecologic cancers.
Your generous donation (100%!) will contribute to the Michael Frumovitz, M.D., Endowment for Gynecologic Rare Tumors.
https://mdanderson.donordrive.com/participant/FrumovitzEndowment